• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Contract manufacturer Kitron raised its guidance for the current year moderately

Analyst Comment03.04.2025 klo 08.50
Antti ViljakainenHead of Research

Translation: Original published in Finnish on 04/03/2025 at 07:49 am EEST

Last night, Norwegian contract manufacturer Kitron raised its guidance for this year. The company now expects 2025 revenue to be 640-710 MEUR (was 600-700 MEUR) and EBIT to be 47-65 MEUR (was 42-63 MEUR). Consequently, the midpoint of the revenue guidance range increased by 4% and the midpoint of the EBIT guidance by 7%. Kitron justified the moderate guidance increase, especially with the strong outlook for the defense and space sectors, as well as the stable outlook for other customer sectors. Kitron expects demand in other sectors to recover this year despite tariffs. Kitron’s other customer segments are related to communications technology, electrification and industry. 

The earnings revision from the peer is also slightly positive news for Finnish contract manufacturers

We consider Kitron a fairly good peer to Scanfil, while Incap has been developing at a somewhat different pace than most of its peers already for a longer time. Although Scanfil's and Incap's weight in the defense sector is clearly lower than Kitron's share of some one-fifth of revenue, the companies' portfolios are closer to each other in other customer sectors. Therefore, we feel Kitron's raised guidance and comments on the stabilization of demand and recovery expectations are a slightly positive signal, especially for Scanfil but also for Incap. In addition, we believe that the very strong growth outlook for the Western defense industry and the need to increase production also open growth opportunities for Scanfil and Incap. 

Login required

This content is only available for logged in users

Create account
Stay up to date
Scanfil
Incap

Forum discussions

Antti has been a busy lead analyst and has produced an extensive report on Scanfil. Like other extensive reports, this one is available for ...
6/17/2026, 7:01 AM
by Sijoittaja-alokas
7
New PRESS release from Scanfil Scanfil is strengthening its collaboration with the AXS division of Bruker’s Life Science & Medtech business....
5/19/2026, 8:49 AM
by Sijoittaja-alokas
5
Hi, it will be available for purchase at Suomalainen Kirjakauppa, and there will also be at least three copies available for borrowing at the...
5/18/2026, 9:37 AM
by Pasi Hiedanpää
4
Hi Pasi! How will it be possible to get this 50th-anniversary work later on if one can’t make it to the fair now?
5/18/2026, 6:42 AM
by JNivala
4
You can find me and the Scanfil Group at the Tampere Investment Fair this week! Stop by our booth B37, and we’ll tell you why Scanfil Plc is...
5/18/2026, 6:32 AM
by Pasi Hiedanpää
10
Here are Nordea’s fresh thoughts on Scanfil We upgrade our fair value range for Scanfil to EUR 11.2-13.7 (10.4-12.7). Its hard work during 2024...
5/16/2026, 10:23 PM
by Sijoittaja-alokas
9
Here are Antti’s comments on the new contract landed by Scanfil. Scanfil announced on Wednesday that it has signed a cooperation agreement with...
5/15/2026, 4:54 AM
by Sijoittaja-alokas
9